National Cancer Institute (NCI): all 3,554 studies

Page 35 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Immunotoxin in Treating Patients With Leukemia or LymphomaCompletedNCT00002765Phase 1
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002759Phase 1
• Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00002745Phase 2
• Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian CancerCompletedNCT00002734Phase 1
• Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002725Phase 2
• Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerCompletedNCT00002723Phase 3
• Topotecan in Treating Children With Refractory LeukemiaCompletedNCT00002705Phase 1
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedNCT00002704Phase 2
• Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002649Phase 3
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorCompletedNCT00002643Phase 2
• Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002625Phase 1
• Lymphocyte Therapy in Treating Patients With Kidney CancerStatus unknownNCT00002589Phase 2
• Paclitaxel Plus Topotecan in Treating Patients With Solid TumorsCompletedNCT00002587Phase 1
• Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002574Phase 2
• Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis FungoidesStatus unknownNCT00002557Phase 2
• Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple MyelomaCompletedNCT00002556Phase 3
• Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung CancerCompletedNCT00002537Phase 1
• Vinorelbine and XR9576 to Treat CancerCompletedNCT00001944Phase 1
• Voriconazole to Treat Fungal InfectionsCompletedNCT00001940Phase 3
• A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)CompletedNCT00001938
• Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 3
• Oxaliplatin in Cancer Patients With Impaired Kidney FunctionCompletedNCT00001835Phase 1
• Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow TransplantsCompletedNCT00001830Phase 1
• p53 Vaccine for Ovarian CancerTerminatedNCT00001827Phase 2
• Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase InhibitorCompletedNCT00001826
• Combination Drug Treatment of Pediatric HIV InfectionCompletedNCT00001818Phase 1
• The Impact of Starbright World on Children Being Treated at the NIHCompletedNCT00001816
• Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of SamplesCompletedNCT00001814
• Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or TrichothiodystrophyCompletedNCT00001813
• A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2CompletedNCT00001812Phase 3
• An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001810Phase 3
• (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic TherapyCompletedNCT00001807
• Methods in Education for Breast Cancer GeneticsCompletedNCT00001806Phase 3
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
• Von Hippel-Lindau Disease Genetic Epidemiology StudyTerminatedNCT00001803
• Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe PsoriasisCompletedNCT00001797Phase 2
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and NeutropeniaCompletedNCT00001790Phase 1
• Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal SequenceCompletedNCT00001705Phase 2
• Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis InfectionCompletedNCT00001702
• Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans InfectionCompletedNCT00001701
• A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their MothersCompletedNCT00001699
• Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCRCompletedNCT00001698Phase 2
• A Pharmacokinetic Study of Genistein, a Tyrosine Kinase InhibitorCompletedNCT00001696Phase 1
• Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical TrialsCompletedNCT00001695
• Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and CarriersCompletedNCT00001693Phase 1
• A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With LeukemiaCompletedNCT00001689Phase 1
• A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and StavudineCompletedNCT00001688Phase 2
• Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare DiseasesCompletedNCT00001686
• Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseCompletedNCT00001685Phase 2
• A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerCompletedNCT00001683Phase 1
• A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus ConcentrationsCompletedNCT00001681
• A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus ErythematosusCompletedNCT00001680Phase 2
• A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the LiverCompletedNCT00001587Phase 1
• Determination of HIV-1 Production by the ProstateCompletedNCT00001584
• Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and CancerCompletedNCT00001582
• Tissue Acquisition for Molecular DiagnosticsCompletedNCT00001580
• A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid TumorsCompletedNCT00001579Phase 1
• Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the ExtremityCompletedNCT00001577Phase 1
• A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the LiverCompletedNCT00001576Phase 1
• A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain TumorsCompletedNCT00001574
• A Phase I Study of SU101 in Pediatric Patients With Refractory MalignancyCompletedNCT00001573Phase 1
• Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin IdiotypeCompletedNCT00001572Phase 1
• A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of OrganochlorinesCompletedNCT00001571
• A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal CancerCompletedNCT00001570Phase 1
• Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal CarcinomatosisCompletedNCT00001569Phase 1
• Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional ModalitiesCompletedNCT00001568Phase 2
• A Phase II Efficacy Study of Roferon-A in Hairy Cell LeukemiaCompletedNCT00001567Phase 2
• Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory MalignancyCompletedNCT00001565Phase 1
• A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric SarcomasCompletedNCT00001564Phase 2
• EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated LymphomaCompletedNCT00001563Phase 2
• Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow TransplantationCompletedNCT00001561Phase 3
• Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated CancersCompletedNCT00001560
• Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen VaccinesCompletedNCT00001512Phase 1
• A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' TumorCompletedNCT00001509Phase 2
• Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast CancerCompletedNCT00001507Phase 1
• A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer PatientsCompletedNCT00001504Phase 1
• Follow-up Protocol for Patients With Cancer/AIDS/Skin DiseaseCompletedNCT00001503
• A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain TumorsCompletedNCT00001502Phase 1
• Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex TraitsCompletedNCT00001500
• Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00001499Phase 2
• A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast CancerCompletedNCT00001498Phase 2
• Assessment of Attentional Functioning in Children With HIV-1 InfectionCompletedNCT00001497
• Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast CancerCompletedNCT00001496
• A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid TumorsCompletedNCT00001495Phase 1
• Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast CancerCompletedNCT00001493Phase 2
• Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLCCompletedNCT00001450Phase 2
• A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer PatientsCompletedNCT00001449Phase 1
• The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV InfectionCompletedNCT00001448
• A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerCompletedNCT00001446Phase 2
• Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 InfectionCompletedNCT00001445Phase 1
• A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory NeoplasmsCompletedNCT00001444Phase 1
• A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV InfectionCompletedNCT00001443Phase 1
• A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck CancerCompletedNCT00001442Phase 1
• Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive ChemotherapyCompletedNCT00001440Phase 1
• A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's AdjuvantCompletedNCT00001439Phase 1
• A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency SyndromesCompletedNCT00001438Phase 2
• Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional FibrosisCompletedNCT00001437Phase 2
• A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With OsteosarcomaCompletedNCT00001436Phase 1
• Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected ChildrenCompletedNCT00001435
• The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic MalignanciesCompletedNCT00001432

← National Cancer Institute (NCI) overview and focus areas